News
BREEZE-AD-PEDS: First data for baricitinib in childhood eczema reported
- Author:
- Sara Freeman
Treatment with the oral JAK inhibitor was significantly more effective than placebo only with the highest dose evaluated.
News
Alopecia areata: Positive results reported for two investigational JAK inhibitors
- Author:
- Sara Freeman
“This is truly transformative therapy,” one of the investigators, Brett King, MD, PhD, said.
News
Study identifies skin biomarkers that predict newborn eczema risk
- Author:
- Sara Freeman
"We are able to identify predictive immune biomarkers of atopic dermatitis using a noninvasive method," the investigator said.
News

Ezetimibe-statin combo lowers liver fat in open-label trial
- Author:
- Sara Freeman
A significant 5.8% decrease in hepatic steatosis was seen after 24 weeks’ treatment with ezetimibe and rosuvastatin comparing baseline with end of...
News

Early age at hysterectomy ups type 2 diabetes risk
- Author:
- Sara Freeman
Having a hysterectomy appears to increase the risk of incident type 2 diabetes, particularly in younger women, and if the ovaries are removed at...
News
Mothers’ diabetes linked to ADHD in their children
- Author:
- Sara Freeman
A small increased risk of ADHD in children born to mothers with diabetes, including pregestational diabetes and gestational diabetes, has been...
News
Apremilast alleviates severe psoriasis in some children, data show
- Author:
- Sara Freeman
“In this randomized, placebo-controlled trial, oral apremilast demonstrated effectiveness and was well tolerated.”
News

Hope shines bright for hidradenitis suppurativa treatments
- Author:
- Sara Freeman
Research into HS is "an incredibly active field at this moment," said Alexa B. Kimball, MD, MPH.
News

Experts express caution over
type 2 diabetes/tea-drinking claim
- Author:
- Sara Freeman
Drinking four cups of tea a day was linked to a 17% lower risk for developing type 2 diabetes in a study, but experts warn these data are...
News

Roflumilast foam effectively eases seborrheic dermatitis
- Author:
- Sara Freeman
The study evaluated a foam formulation of roflumilast, a PDE4 inhibitor that is available for topical use in a cream formulation that was recently...
News

Overall survival dips with vitamin D deficiency in melanoma
- Author:
- Sara Freeman
The research adds to existing evidence that “vitamin D levels can play an important and independent role in patients’ survival outcomes.”
News

Finding HBV ‘cure’ may mean going ‘back to the drawing board’
- Author:
- Sara Freeman
Development of new HBV drugs looks more complicated than initially expected, and it’s time to refine and refocus goals, according to one...
News

Statins in NAFLD: Taking a closer look at benefits
- Author:
- Sara Freeman
Statins could have multiple benefits in NAFLD, but there has been little insight into how they may be exerting such effects.
News

Phase 3 data shows bulevirtide benefit in hepatitis D
- Author:
- Sara Freeman
“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.”
News

Pemvidutide promising for fatty liver disease
- Author:
- Sara Freeman
Weight loss and multiple improvements in lipid parameters linked to nonalcoholic fatty liver disease were seen in a phase 1 trial.